Heparin dosing score protocol for anticoagulation during polymyxin B hemoperfusion

J Formos Med Assoc. 2018 Jul;117(7):652-653. doi: 10.1016/j.jfma.2018.03.001. Epub 2018 Mar 16.

Authors

Chen-Tse Lee¹, Anne Chao¹, Chien-Heng Lai², Yu-Chang Yeh³

Affiliations

¹ Department of Anesthesiology, National Taiwan University Hospital, No. 7, Chung-Shan S. Road, Taipei, Taiwan.
² Department of Surgery, National Taiwan University Hospital, No. 7, Chung-Shan S. Road, Taipei, Taiwan.
³ Department of Anesthesiology, National Taiwan University Hospital, No. 7, Chung-Shan S. Road, Taipei, Taiwan. Electronic address: tonyyeh@ntuh.gov.tw.

PMID: 29555453
DOI: 10.1016/j.jfma.2018.03.001

No abstract available

Publication types

Letter

MeSH terms

Aged
Anti-Bacterial Agents / therapeutic use
Anticoagulants / therapeutic use*
Blood Coagulation / drug effects
Female
Hemoperfusion / methods*
Heparin / administration & dosage*
Heparin / adverse effects
Humans
Male
Middle Aged
Polymyxin B / therapeutic use*
Shock, Septic / drug therapy
Shock, Septic / therapy
Treatment Outcome

Substances

Anti-Bacterial Agents
Anticoagulants
Heparin
Polymyxin B